Methemoglobin formation generally occurs during sulfanilamide therapy in humans (1, 2, 3, 4, 5) . From the clinical statistics on methemoglobinemia it has been deduced that sulfanilamide is partially converted by the body into some active agent which can function as an oxidant (5). It is the purpose of this paper to determine whether the oxidation of hemoglobin is performed by sulfanilamide itself or whether the active agent is produced through the interaction of tissues and sulfanilamide.
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METHODS
Normal animals were killed by a blow on the head followed by decapitation. The tissues were removed and slices of 0.2 to 0.4 mm. thickness were immediately prepared. These were suspended in 5 ml. Ringer-phosphate solution of pH 7.4 (6) containing 0.1 gram per cent glucose, varying concentrations of sulfanilamide, and the saline-washed erythrocytes from approximately 0.5 ml. of normal human blood. The mixtures were placed in 50 ml. Erlenmeyer flasks and were shaken constantly in a water bath at 37.50 C. for approximately 2 hours. The tissue slices were removed, dried, and weighed. The dry weight was generally between 30 and 50 mgm. The red cells were centrifuged, washed with physiological saline, hemolyzed with saponin, and diluted to 10 ml. with 1/20 M pH 7.4 phosphate buffer. Methemoglobin and total hemoglobin were determined spectrophotometrically by the change in extinction at 634 m,u upon conversion to cyanmethemoglobin (7) . The presence of methemoglobin was confirmed by the disappearance of the alpha band upon the addition of cyanide, hydrosulfite, and ammonium hydroxide. Furthermore, the percentage of methemoglobin in the mixture as determined from the ratio of the extinctions at 575 m,u to 560 m,u (8) checked with the quantity as previously determined. Only methemoglobin could give these results. The bands of pigments other than met-521 hemoglobin and oxyhemoglobin were not detected with the hand spectroscope.
EXPERIMENTAL DATA
The incubation of erythrocytes with Ringerphosphate solution containing from 0 to 250 mgm. per cent of sulfanilamide never caused the conversion of more than 1 per cent of the total hemoglobin to methemoglobin. The incubation of erythrocytes with tissue slices of the liver, kidney, muscle, spleen of the mouse, rabbit, rat, cat, and guinea pig, was likewise without appreciable effect on the hemoglobin. However, when liver slices were incubated with sulfanilamide and red cells, the formation of methemoglobin invariably occurred. A sample protocol is shown in Table I . Similar results were obtained with the livers of the cat, guinea pig, and rabbit. Other animals were not tried. These results are shown in Figure Results obtained with the kidneys of the rat and mouse are shown in Figure 2 . The mouse kidney is very effective, while the rat kidney is a much less efficient preparation. Unequivocal results were not obtained with the muscle or spleen of the cat, rat, mouse, rabbit, or guinea pig, nor with the kidney of the guinea pig or cat, nor with the brain of the rabbit or cat. Since the active agent is formed through the action of kidney, it is evident that this process is not related to the acetylation of sulfanilamide. The latter is not performed by the surviving kidney (9 This process may be repeated several times. natant fluid was incubated for 45 minutes with red cells and the formation of methemoglobin resulted. The supernatant fluid from this reaction was again incubated with fresh red cells and methemoglobin was again formed. The results are seen in Table III-B. These effects might occur because all of the oxidizing agent had not been utilized in an irreversible reaction by the first addition of red cells. However, a consideration of the rate of reaction shows that methemoglobin formation tends to reach a maximum at the end of 45 to 60 minutes even when high concentrations of sulfanilamide are used. This is shown in Figure  3 where the supernatant fluid from the mixture in Ringer-phosphate containing 100 mgm. per cent of sulfanilamide was incubated with red cells for varying lengths of time. Nevertheless, if fresh red cells are incubated with the supernatant fluid (see Table III ever, caused the production of 34 mgm. of methemoglobin in the same period of time when incubated with double the quantity of red cells. The ratio of oxidized hemoglobin to total hemoglobin thus remains relatively the same. These results seem best to be explained by the action of a redox system on the hemoglobin-methemoglobin system.
The most intense methemoglobin formation per mgm. of sulfanilamide occurred when liver slices were incubated with red cells in 5 ml. of a solution containing 10 mgm. per cent of sulfanilamide, 14 mgm. of methemoglobin being formed. This quantity of sulfanilamide, if converted into a monovalent oxidizing agent, would be equivalent to 48.5 mgm. of hemoglobin. Therefore 29 per cent of the theoretical yield was obtained. It is probable, however, that most of the sulfanilamide is not converted into an active agent. It has been found that the destruction of sulfanilamide by the surviving liver as tested by the method of Marshall (10) is negligible (9) . Unless the amino group is held intact during the formation of the active agent, the substance must be autoxidizable and must act as a catalytic reversible redox system. Furthermore, when the supernatant fluid from the incubation of rat liver slices in sulfanilamide solutions is mixed with 10 It is possible that the active agent may owe its effect to an anticatalase action. Accumulation of hydrogen peroxide during the metabolism of the red cells might result and might cause the oxidation of hemoglobin to methemoglobin. To eliminate this possibility, the following experiment was performed. Liver slices were incubated in Ringer-phosphate solution containing 100 mgm. per cent of sulfanilamide. The supernatant fluid after centrifugalization was incubated for 30 minutes with human red cells. The mixture was then hemolyzed with saponin. The same procedure was followed in another vessel save that the supernatant fluid of liver slices incubated in Ringer-phosphate solution without sulfanilamide was used. To each mixture of hemolyzed cells and supernatant fluid was added a small amount of hydrogen peroxide and the oxygen evolution was measured manometrically in the Warburg apparatus. The rate and extent of the catalase action were found to be identical in both mixtures.
The extent of methemoglobin formation in the preparation containing sulfanilamide was then compared with another similar preparation which had not been mixed with hydrogen peroxide. No change in the amount could be detected although both had much more methemoglobin than did the control without sulfanilamide. The entire experiment was then repeated with the exception that the red cells were not hemolyzed before the addition of the peroxide, and the same results were obtained. If the active agent acted through anticatalase action, the oxygen evolution after the addition of hydrogen peroxide should have been slower in the solutions containing sulfanilamide and an increased formation of methemoglobin should have resulted in those solutions when peroxide was added.
Using the technique of testing the supernatant fluids (from the incubation of tissue and sulfanilamide) with red cells, it has been found that precipitation of the protein with trichloracetic acid does not remove the active substance. The agent is dialyzable through ordinary viscose membranes, is relatively stable at QO, and is destroyed by boiling. The substance can exert its action on red cells when they are suspended in serum.
DISCUSSION
The formation of an oxidizing agent from sulfanilamide by tissues adequately explains the methemoglobinemia which has been found in patients treated with this drug. Clinical methemoglobemia has been noted to depend upon the concentration of sulfanilamide in the blood, and to reach a peak several hours after the sulfanilamide concentration of the blood had reached its peak (5) . The methemoglobinemia of patients was also found to depend slightly upon the concentration of circulating hemoglobin. All Rimington (13) has suggested that the agent causing methemoglobinemia may also account for the excess porphyrin excretion seen during sulfanilamide therapy. The proof of this possibility and the relation of the agent to other toxic manifestations must await the isolation of larger quantities of the active agent.
The oxidizing agent may account for some of the therapeutic properties of the drug. Levaditi and Vaisman (14) have shown that sulfanilamide which has been absorbed via the gastro-intestinal tract seems to be more potent than locally applied sulfanilamide, and they believed that the gastrointestinal tract or viscera caused some change in the drug. It is planned to study the bactericidal activity of the agent. 
